Glenzocimab for reperfusion in the setting of endovascular therapy for brain infarction: GREEN study
glenzocimabacute ischemic strokeAIS
… 24 hours, will be randomized to one of two groups: intravenous glenzocimab 1000 mg with standard of care (SoC-EVT±IVT) or SoC (EVT±IVT) pl…